相似文献
1
Insulin neuroprotection and the mechanisms.
Chin Med J (Engl). 2015 Apr 5;128(7):976-81. doi: 10.4103/0366-6999.154323.
2
The essential role of endothelial nitric oxide synthase activation in insulin-mediated neuroprotection against ischemic stroke in diabetes.
J Vasc Surg. 2014 Feb;59(2):483-91. doi: 10.1016/j.jvs.2013.03.023. Epub 2013 May 7.
3
Histamine up-regulates astrocytic glutamate transporter 1 and protects neurons against ischemic injury.
Neuropharmacology. 2014 Feb;77:156-66. doi: 10.1016/j.neuropharm.2013.06.012. Epub 2013 Jun 18.
4
Insulin attenuates ischemic brain damage independent of its hypoglycemic effect.
J Cereb Blood Flow Metab. 1991 Nov;11(6):1006-14. doi: 10.1038/jcbfm.1991.168.
5
Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia.
J Neurosurg. 2004 Oct;101(4):664-8. doi: 10.3171/jns.2004.101.4.0664.
6
Neuroprotection by nitrous oxide: facts and evidence.
Crit Care Med. 2008 Sep;36(9):2651-9. doi: 10.1097/CCM.0b013e318183f646.
7
Insulin reduction of cerebral infarction due to transient focal ischemia.
J Neurosurg. 1995 Feb;82(2):262-8. doi: 10.3171/jns.1995.82.2.0262.
8
Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
Consult Pharm. 2009 Jun;24 Suppl B:18-24.
9
Special issues: glucose and the brain.
Crit Care Med. 1992 Jan;20(1):104-14.
10
Neuroprotection in acute brain injury: an up-to-date review.
Crit Care. 2015 Apr 21;19(1):186. doi: 10.1186/s13054-015-0887-8.
引用本文的文献
1
Pancreatic β cell-secreted factor FGF23 attenuates Alzheimer's disease-related amyloid β-induced neuronal death.
PNAS Nexus. 2025 Jan 28;4(1):pgae542. doi: 10.1093/pnasnexus/pgae542. eCollection 2025 Jan.
2
Intranasal Insulin for Treatment of Persistent Post-COVID-19 Olfactory Dysfunction: A Scoping Review.
J Community Hosp Intern Med Perspect. 2024 Sep 9;14(5):55-62. doi: 10.55729/2000-9666.1390. eCollection 2024.
3
Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line.
Metabolites. 2023 Jul 4;13(7):817. doi: 10.3390/metabo13070817.
4
Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis.
Neurol Sci. 2023 Dec;44(12):4193-4203. doi: 10.1007/s10072-023-06965-9. Epub 2023 Jul 27.
5
Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature.
Front Neurol. 2022 May 31;13:870141. doi: 10.3389/fneur.2022.870141. eCollection 2022.
6
Impaired glucose metabolism reduces the neuroprotective action of adipocytokines in cognitively normal older adults with insulin resistance.
Aging (Albany NY). 2021 Nov 3;13(21):23936-23952. doi: 10.18632/aging.203668.
7
Does glitazone treatment have a role on the prevention of Parkinson's disease in adult diabetic population? A systematic review.
Metab Brain Dis. 2020 Oct;35(7):1067-1075. doi: 10.1007/s11011-020-00568-5. Epub 2020 May 4.
8
Improvement of spatial learning and memory, cortical gyrification patterns and brain oxidative stress markers in diabetic rats treated with leaf extract and vitexin.
J Tradit Complement Med. 2017 Jun 20;8(1):190-202. doi: 10.1016/j.jtcme.2017.05.006. eCollection 2018 Jan.
9
The association between PGC-1α and Alzheimer's disease.
Anat Cell Biol. 2016 Mar;49(1):1-6. doi: 10.5115/acb.2016.49.1.1. Epub 2016 Mar 28.
10
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.
CNS Drugs. 2015 Dec;29(12):1023-39. doi: 10.1007/s40263-015-0301-8.
本文引用的文献
1
Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats.
Endocrinology. 2014 Apr;155(4):1235-46. doi: 10.1210/en.2013-1593. Epub 2014 Jan 17.
2
Cytochrome C is tyrosine 97 phosphorylated by neuroprotective insulin treatment.
PLoS One. 2013 Nov 5;8(11):e78627. doi: 10.1371/journal.pone.0078627. eCollection 2013.
3
Insulin promotes glycogen storage and cell proliferation in primary human astrocytes.
PLoS One. 2011;6(6):e21594. doi: 10.1371/journal.pone.0021594. Epub 2011 Jun 27.
4
Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.
Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R668-73. doi: 10.1152/ajpregu.00058.2011. Epub 2011 Jun 15.
5
Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites.
J Neurosci. 2011 Mar 23;31(12):4622-35. doi: 10.1523/JNEUROSCI.3541-10.2011.
6
Dynamic monitoring of cytosolic glucose in single astrocytes.
Glia. 2011 Jun;59(6):903-13. doi: 10.1002/glia.21161. Epub 2011 Mar 4.
7
Ischemic hippocampal cell death induces glucose dysregulation by attenuating glucose-stimulated insulin secretion which is exacerbated by a high fat diet.
Life Sci. 2011 Apr 25;88(17-18):766-73. doi: 10.1016/j.lfs.2011.02.021. Epub 2011 Feb 26.
8
Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current.
PLoS One. 2011 Jan 14;6(1):e16188. doi: 10.1371/journal.pone.0016188.
9
Brain glycogen supercompensation in the mouse after recovery from insulin-induced hypoglycemia.
J Neurosci Res. 2011 Apr;89(4):585-91. doi: 10.1002/jnr.22579. Epub 2011 Jan 21.
10
Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.
Antioxid Redox Signal. 2011 May 15;14(10):1829-39. doi: 10.1089/ars.2010.3816. Epub 2011 Mar 8.
Zotero 插件